Fingerprint
Dive into the research topics of 'Long-term response to imatinib is not affected by the initial dose in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: Final update from the Tyrosine Kinase Inhibitor Optimization and Selectivity (TOPS) study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically